Search Results
Baxter to Host its Annual Meeting of Stockholders in Virtual Format
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and recommendations and orders from Federal and Illinois authorities, its Annual Meeting of Stockholders (the 2020 Annual Meeting) will now be held by means of a virtual format only.
Baxter Reports Fourth-Quarter and Full-Year 2019 Results, Completes Financial Restatement Process
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced its complete financial results for the fourth quarter and full year ended December 31, 2019.
Defining Moments from Simple Conversations
"I believe defining moments can come from big events, but if you listen closely they often come from simple conversations."
Baxter to Host Fourth-Quarter 2019 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2019 financial results on Tuesday, March 17, 2020, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international). Please dial into the call at least ten minutes prior to the start for the operator to connect you. The Conference ID is 3463329.
Baxter Launches Peri-Strips Dry with Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical Procedures
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, announced 510(k) clearance from the U.S. Food and Drug Administration for a new generation of its Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, known as PSDV with Secure Grip.
Baxter to Present at the Raymond James 41st Annual Institutional Investors Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 41st Annual Institutional Investors Conference in Orlando, Fla. on Monday, March 2, 2020. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:05 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through April 1, 2020.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on April 1, 2020, to shareholders of record as of February 28, 2020. The indicated annual dividend rate is $0.88 per share of common stock.
Baxter Completes Acquisition of Seprafilm Adhesion Barrier
Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million.
Baxter and COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ Indirect Calorimetry Device
Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry (IC) technology. IC is considered the "gold standard"1 to accurately measure a patient’s calorie needs, or resting energy expenditure (REE).
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Spectral Medical Inc. (TSX:EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a distribution agreement for TORAYMYXIN™ PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay™ (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis.